|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Arysta LifeScience Corp., of Tokyo, named Christopher Richards president and CEO. John Hagaman, who has been serving as interim CEO, was appointed chairman. An agrochemical company, Arysta provides crop protection and life science products.
o Ash Stevens Inc., of Detroit, received approval from the FDA to manufacture the bulk drug substance 5-azacitidine for Boulder, Colo.-based Pharmion Corp.'s Vidaza, a treatment for patients with myelodysplastic syndromes. The FDA approved Vidaza to treat all five MDS subtypes last week. The substance will be manufactured in Ash Steven's Riverview, Mich., manufacturing facility. (See BioWorld Today, May 21, 2004.)
...